Literature DB >> 17935988

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC.

Melissa A VanAlstine1, Mark P Wentland, Dana J Cohen, Jean M Bidlack.   

Abstract

A series of aryl-containing N-monosubstituted analogues of the lead compound 8-[N-((4'-phenyl)-phenethyl)]-carboxamidocyclazocine were synthesized and evaluated to probe a putative hydrophobic binding pocket of opioid receptors. Very high binding affinity to the mu opioid receptor was achieved though the N-(2-(4'-methoxybiphenyl-4-yl)ethyl) analogue of 8-CAC. High binding affinity to mu and very high binding affinity to kappa opioid receptors was observed for the N-(3-bromophenethyl) analogue of 8-CAC. High binding affinity to all three opioid receptors were observed for the N-(2-naphthylethyl) analogue of 8-CAC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935988      PMCID: PMC2137165          DOI: 10.1016/j.bmcl.2007.09.082

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.

Authors:  John L Neumeyer; Ao Zhang; Wennan Xiong; Xiao-Hui Gu; James E Hilbert; Brian I Knapp; S Stevens Negus; Nancy K Mello; Jean M Bidlack
Journal:  J Med Chem       Date:  2003-11-20       Impact factor: 7.446

2.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.

Authors:  Mark P Wentland; Melissa VanAlstine; Robert Kucejko; Rongliang Lou; Dana J Cohen; Amy L Parkhill; Jean M Bidlack
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 3.  Cyclazocine revisited.

Authors:  S Archer; S D Glick; J M Bidlack
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

4.  A manual method for applying the Hansch approach to drug design.

Authors:  J G Topliss
Journal:  J Med Chem       Date:  1977-04       Impact factor: 7.446

5.  8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines.

Authors:  M P Wentland; R Lou; Y Ye; D J Cohen; G P Richardson; J M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2001-03-12       Impact factor: 2.823

6.  Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.

Authors:  Mark P Wentland; Yingchun Ye; Christopher L Cioffi; Rongliang Lou; Qun Zhou; Guoyou Xu; Wenhu Duan; Christoph M Dehnhardt; Xufeng Sun; Dana J Cohen; Jean M Bidlack
Journal:  J Med Chem       Date:  2003-02-27       Impact factor: 7.446

7.  8-Carboxamidocyclazocine: a long-acting, novel benzomorphan.

Authors:  Jean M Bidlack; Dana J Cohen; Jay P McLaughlin; Rongliang Lou; Yingchun Ye; Mark P Wentland
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

  7 in total
  4 in total

Review 1.  Controlled microwave heating in modern organic synthesis: highlights from the 2004-2008 literature.

Authors:  C Oliver Kappe; Doris Dallinger
Journal:  Mol Divers       Date:  2009-04-21       Impact factor: 2.943

2.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors.

Authors:  Melissa A VanAlstine; Mark P Wentland; Juan Alvarez; Qing Cao; Dana J Cohen; Brian I Knapp; Jean M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2013-02-08       Impact factor: 2.823

3.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC.

Authors:  Mark P Wentland; Sunjin Jo; Joseph M Gargano; Melissa A VanAlstine; Dana J Cohen; Jean M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2012-10-27       Impact factor: 2.823

4.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.

Authors:  Mark P Wentland; Xufeng Sun; Dana J Cohen; Jean M Bidlack
Journal:  Bioorg Med Chem       Date:  2008-03-30       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.